27Aug/23
CD8-Positive T Cell Surface FcγRIIB Limits the Efficacy of PD-1 Inhibitors
Recently, a research team from Emory University in the United States published their latest research findings in “Science Translational Medicine,” revealing for the first time that the immune-inhibitory receptor FcγRIIB on theRead More…